aluates Reports

$ 0.0

Automative

Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-3X6389

Global Amyotrophic Lateral Sclerosis Lou Gehrig s Disease Treatment Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Research Report 2025

Code: QYRE-Auto-3X6389

Report

September 2025

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GNT Pharma

Amkor Pharma

Synthetic Biologics

Mitsubishi Tanabe Pharma

Avicena

Sanofi

Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size

The global market for Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment was valued at US$ 321 million in the year 2024 and is projected to reach a revised size of US$ 404 million by 2031, growing at a CAGR of 3.4% during the forecast period.

Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market

Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.

The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person"s parents. About half of these genetic cases are due to one of two specific genes. The underlying mechanism involves damage to both upper and lower motor neurons. The diagnosis is based on a person"s signs and symptoms, with testing done to rule out other potential causes.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment.

The Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Report

Report Metric	Details
Report Name	Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market
Accounted market size in year	US$ 321 million
Forecasted market size in 2031	US$ 404 million
CAGR	3.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Chemotherapy Stem Cell Therapy
Segment by Application	Hospitals Diagnostic Centres Clinics Retail Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GNT Pharma, Amkor Pharma, Synthetic Biologics, Mitsubishi Tanabe Pharma, Avicena, Sanofi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market growing?

Ans: The Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market witnessing a CAGR of 3.4% during the forecast period 2025-2031.

What is the Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market size in 2031?

Ans: The Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market size in 2031 will be US$ 404 million.

Who are the main players in the Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market report?

Ans: The main players in the Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market are GNT Pharma, Amkor Pharma, Synthetic Biologics, Mitsubishi Tanabe Pharma, Avicena, Sanofi

What are the Application segmentation covered in the Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market report?

Ans: The Applications covered in the Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market report are Hospitals, Diagnostic Centres, Clinics, Retail Pharmacies

What are the Type segmentation covered in the Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market report?

Ans: The Types covered in the Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market report are Chemotherapy, Stem Cell Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Chemotherapy

1.2.3 Stem Cell Therapy

1.3 Market by Application

1.3.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Diagnostic Centres

1.3.4 Clinics

1.3.5 Retail Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Perspective (2020-2031)

2.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Growth Trends by Region

2.2.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Historic Market Size by Region (2020-2025)

2.2.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Region (2026-2031)

2.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Dynamics

2.3.1 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Industry Trends

2.3.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Drivers

2.3.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Challenges

2.3.4 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Revenue

3.1.1 Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Revenue (2020-2025)

3.1.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue

3.4 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Concentration Ratio

3.4.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue in 2024

3.5 Global Key Players of Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Head office and Area Served

3.6 Global Key Players of Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment, Product and Application

3.7 Global Key Players of Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Breakdown Data by Type

4.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Historic Market Size by Type (2020-2025)

4.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Type (2026-2031)

5 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Breakdown Data by Application

5.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Historic Market Size by Application (2020-2025)

5.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2020-2031)

6.2 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2020-2025)

6.4 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2020-2031)

7.2 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2020-2025)

7.4 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2020-2031)

8.2 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2020-2031)

9.2 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2020-2025)

9.4 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2020-2031)

10.2 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GNT Pharma

11.1.1 GNT Pharma Company Details

11.1.2 GNT Pharma Business Overview

11.1.3 GNT Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction

11.1.4 GNT Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2020-2025)

11.1.5 GNT Pharma Recent Development

11.2 Amkor Pharma

11.2.1 Amkor Pharma Company Details

11.2.2 Amkor Pharma Business Overview

11.2.3 Amkor Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction

11.2.4 Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2020-2025)

11.2.5 Amkor Pharma Recent Development

11.3 Synthetic Biologics

11.3.1 Synthetic Biologics Company Details

11.3.2 Synthetic Biologics Business Overview

11.3.3 Synthetic Biologics Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction

11.3.4 Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2020-2025)

11.3.5 Synthetic Biologics Recent Development

11.4 Mitsubishi Tanabe Pharma

11.4.1 Mitsubishi Tanabe Pharma Company Details

11.4.2 Mitsubishi Tanabe Pharma Business Overview

11.4.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction

11.4.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2020-2025)

11.4.5 Mitsubishi Tanabe Pharma Recent Development

11.5 Avicena

11.5.1 Avicena Company Details

11.5.2 Avicena Business Overview

11.5.3 Avicena Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction

11.5.4 Avicena Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2020-2025)

11.5.5 Avicena Recent Development

11.6 Sanofi

11.6.1 Sanofi Company Details

11.6.2 Sanofi Business Overview

11.6.3 Sanofi Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction

11.6.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2020-2025)

11.6.5 Sanofi Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

GNT Pharma

Amkor Pharma

Synthetic Biologics

Mitsubishi Tanabe Pharma

Avicena

Sanofi

List of Tables

Table 1. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Chemotherapy

Table 3. Key Players of Stem Cell Therapy

Table 4. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Region (2020-2025)

Table 8. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Region (2026-2031)

Table 10. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Trends

Table 11. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Drivers

Table 12. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Challenges

Table 13. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Restraints

Table 14. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Players (2020-2025)

Table 16. Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment as of 2024)

Table 17. Ranking of Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment, Headquarters and Area Served

Table 20. Global Key Players of Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment, Product and Application

Table 21. Global Key Players of Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Type (2020-2025)

Table 25. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Type (2026-2031)

Table 27. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Application (2020-2025)

Table 29. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Application (2026-2031)

Table 31. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. GNT Pharma Company Details

Table 47. GNT Pharma Business Overview

Table 48. GNT Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product

Table 49. GNT Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2020-2025) & (US$ Million)

Table 50. GNT Pharma Recent Development

Table 51. Amkor Pharma Company Details

Table 52. Amkor Pharma Business Overview

Table 53. Amkor Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product

Table 54. Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2020-2025) & (US$ Million)

Table 55. Amkor Pharma Recent Development

Table 56. Synthetic Biologics Company Details

Table 57. Synthetic Biologics Business Overview

Table 58. Synthetic Biologics Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product

Table 59. Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2020-2025) & (US$ Million)

Table 60. Synthetic Biologics Recent Development

Table 61. Mitsubishi Tanabe Pharma Company Details

Table 62. Mitsubishi Tanabe Pharma Business Overview

Table 63. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product

Table 64. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2020-2025) & (US$ Million)

Table 65. Mitsubishi Tanabe Pharma Recent Development

Table 66. Avicena Company Details

Table 67. Avicena Business Overview

Table 68. Avicena Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product

Table 69. Avicena Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2020-2025) & (US$ Million)

Table 70. Avicena Recent Development

Table 71. Sanofi Company Details

Table 72. Sanofi Business Overview

Table 73. Sanofi Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product

Table 74. Sanofi Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2020-2025) & (US$ Million)

Table 75. Sanofi Recent Development

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

Table 79. Authors List of This Report

List of Figures

Figure 1. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Picture

Figure 2. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type: 2024 VS 2031

Figure 4. Chemotherapy Features

Figure 5. Stem Cell Therapy Features

Figure 6. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Diagnostic Centres Case Studies

Figure 10. Clinics Case Studies

Figure 11. Retail Pharmacies Case Studies

Figure 12. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Report Years Considered

Figure 13. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Region: 2024 VS 2031

Figure 16. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Players in 2024

Figure 17. Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue in 2024

Figure 19. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Country (2020-2031)

Figure 21. United States Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Country (2020-2031)

Figure 25. Germany Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Region (2020-2031)

Figure 33. China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Country (2020-2031)

Figure 41. Mexico Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Country (2020-2031)

Figure 45. Turkey Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. GNT Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2020-2025)

Figure 49. Amkor Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2020-2025)

Figure 50. Synthetic Biologics Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2020-2025)

Figure 51. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2020-2025)

Figure 52. Avicena Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2020-2025)

Figure 53. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2020-2025)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Autism Drug Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9T16706

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ADHD Planner App Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34C16185

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Autism Digital Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2E16662

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-25A16539

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions